• Evaluation of SB-007 Safety and Efficacy in Patients with Stargardt Disease Type 1 (STGD1) Caused by ABCA4 Gene Mutations

    Recruiting

    2 1 1
    Investigated Drugs:
    Belgium Germany

  • Study of mRNA-4157 and Pembrolizumab for Patients with Metastatic Melanoma

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Greece Italy Poland Portugal +1

  • Evaluation of Hydrocortisone, Octreotide, and Teres Ligament Patch Combination to Prevent Complications After Pancreatoduodenectomy in Patients with Pancreatic Head Cancer or IPMN

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium Denmark Finland Italy The Netherlands Norway +1

  • Study Comparing Single and Dual Antiplatelet Therapy with Clopidogrel and Acetylsalicylic Acid in Elderly Patients or Those at Risk of Bleeding After Balloon Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium Italy Luxembourg Spain

  • Study of WSD0922-FU for Patients with Advanced Non-Small Cell Lung Cancer and C797S Mutation After Osimertinib Treatment

    Recruiting

    2 1 1
    France

  • Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium Bulgaria Czechia Denmark Germany Hungary +6

  • Evaluating NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder Who Are Not Responding Adequately to Current Therapy

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Finland Hungary Latvia

  • Evaluation of Choline Chloride for Intestinal Failure Patients Receiving Long-Term Parenteral Support

    Recruiting

    4 1
    Belgium Denmark France Germany Poland

  • Study Comparing Golcadomide and Rituximab with Other Treatments for Patients with Relapsed or Refractory Follicular Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland France Germany Greece Italy The Netherlands +2

  • Assessment of NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Lithuania Romania Slovakia

powered by